[ad_1] <br><strong>AI-Designed Dual ATR-mTOR Inhibitor Demonstrates In Vivo Efficacy; Novel LNP Formulation of Bifunctional PARP/HDAC Inhibitor kt-3283 Successfully Characterized</strong> <a href="https://financialpost.com/globe-newswire/rakovina-therapeutics-presents-new-preclinical-data-at-aacr-2026-annual-meeting?utm_source=rss&utm_medium=feed&utm_campaign=truncated_content&utm_content=globenewswire&utm_term=globenewswire">Read More</a> <br><a href="https://financialpost.com/globe-newswire/rakovina-therapeutics-presents-new-preclinical-data-at-aacr-2026-annual-meeting">Read More </a>
